Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study - Role of intra-Clonal HEterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias Accéder directement au contenu
Article Dans Une Revue Pharmacoepidemiology and Drug Safety Année : 2017

Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study

Domaines

Hématologie
Fichier non déposé

Dates et versions

hal-01659732 , version 1 (08-12-2017)

Identifiants

Citer

Pernelle Noize, Angela Grelaud, Jacques-Olivier Bay, Christine Chevreau, Marine Gross-Goupil, et al.. Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study. Pharmacoepidemiology and Drug Safety, 2017, 26 (2), pp.1561-1569. ⟨10.1002/pds.4228⟩. ⟨hal-01659732⟩
68 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More